Perseon Cancer Ablation Therapy Expanded To Treat Liver Tumors

The newly renamed company says FDA has cleared its MicroThermX microwave ablation system to treat complicated non-resectable liver tumors.

FDA has cleared an expanded indication for Perseon's microwave ablation system MicroThermX to treat complicated non-resectable liver tumors.

Perseon, formerly known as BSD Medical Corp., has had a 510(k) clearance on MicroThermX for ablation of soft tissue...

More from Archive

More from Medtech Insight